Developmental dysplasia of the hip, suppurative hip arthritis, avascular necrosis of the femoral head,Perthes disease, transient synovitis,femoral fractures, femoral tumors
Conditions
Interventions
Experimental group:None
Control group (elasticity imaging study only): Neonatal group:None
Control group (elasticity imaging study only): Infant group:None
Control group (elasticity imaging study only): Toddler group:None
Control group (elasticity imaging study only): Preschool-age group:None
Control group (elasticity imaging study only): School-age group:None
Control group (elasticity imaging study only): Adolescent group:None
Sponsors
Children's Hospital of Chongqing Medical University
Eligibility
Sex/Gender
All
Age
No minimum to 18 Years
Inclusion criteria
Inclusion criteria: Experimental Group 1. Patients diagnosed with unilateral DDH, suppurative hip arthritis, avascular necrosis of the femoral head, femoral fractures, or other conditions necessitating hip surgery; 2. Age 0-18 years; 3. The patient or their family consent to undergo contrast-enhanced ultrasound and voluntarily participate in this project by signing the informed consent form; Control group inclusion criteria (elastography study only): Children undergoing health examinations at our hospital with no history of hip joint disease or surgery.
Exclusion criteria
Exclusion criteria: 1. Known hypersensitivity to sulfur hexafluoride (SF6) or any component of SonoVue®; 2. Have a clear history of rash or allergies in the past; 3. Children with conditions affecting cardiopulmonary function, including congenital heart disease with right-to-left shunt, severe pulmonary hypertension, critical respiratory failure, myocarditis, cardiomyopathy, pericarditis, endocarditis, arrhythmia, severe pneumonia, bronchial asthma, bleeding disorders, renal failure, and uncontrolled hypertension, as well as those requiring urgent surgical intervention; 4. Failure to obtain the consent of parents or legal guardians.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vessel Density,VD;Flow Weighted Density of the vessel,FWVD;Perfusion Index,PI;Peak Intensity,PI;Ascending Slope,AS;viscosity coefficient;Shear wave velocity;Mean transit time,MTT;Fractal dimension,FD;Mean Velocity;Max Velocity;Time to peak; | — |
Countries
China
Contacts
Public ContactTang Yi
Children's Hospital of Chongqing Medical University
Outcome results
None listed